Published in Arterioscler Thromb Vasc Biol on June 01, 1999
Immune and inflammatory mechanisms of atherosclerosis (*). Annu Rev Immunol (2009) 5.28
Inhibition of monocyte adhesion to endothelial cells and attenuation of atherosclerotic lesion by a glucagon-like peptide-1 receptor agonist, exendin-4. Diabetes (2010) 2.34
The inflammation highway: metabolism accelerates inflammatory traffic in obesity. Immunol Rev (2012) 2.01
Adipocyte fatty acid-binding protein, aP2, alters late atherosclerotic lesion formation in severe hypercholesterolemia. Arterioscler Thromb Vasc Biol (2002) 1.94
Heterogeneity of human macrophages in culture and in atherosclerotic plaques. Am J Pathol (2008) 1.86
MicroRNA-155 promotes atherosclerosis by repressing Bcl6 in macrophages. J Clin Invest (2012) 1.77
Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest (2001) 1.72
Toll-like receptor 2 plays a critical role in the progression of atherosclerosis that is independent of dietary lipids. Atherosclerosis (2007) 1.67
Visceral adipose tissue inflammation accelerates atherosclerosis in apolipoprotein E-deficient mice. Circulation (2008) 1.62
Exenatide exerts a potent antiinflammatory effect. J Clin Endocrinol Metab (2011) 1.37
The role of chemokines in recruitment of immune cells to the artery wall and adipose tissue. Vascul Pharmacol (2009) 1.27
Genetic modifiers of atherosclerosis in mice. Arterioscler Thromb Vasc Biol (2000) 1.22
Oxidized LDL reduces monocyte CCR2 expression through pathways involving peroxisome proliferator-activated receptor gamma. J Clin Invest (2000) 1.16
Phospholipase C beta3 deficiency leads to macrophage hypersensitivity to apoptotic induction and reduction of atherosclerosis in mice. J Clin Invest (2008) 1.09
Arsenic exacerbates atherosclerotic lesion formation and inflammation in ApoE-/- mice. Toxicol Appl Pharmacol (2009) 1.08
Statins suppress interleukin-6-induced monocyte chemo-attractant protein-1 by inhibiting Janus kinase/signal transducers and activators of transcription pathways in human vascular endothelial cells. Br J Pharmacol (2010) 1.07
Monocyte chemoattractant protein-1 deficiency protects against visceral fat-induced atherosclerosis. Arterioscler Thromb Vasc Biol (2010) 1.05
Up-regulation of tissue factor in human pulmonary artery endothelial cells after ultrafine particle exposure. Environ Health Perspect (2007) 1.03
Omega-3 fatty acid oxidation products prevent vascular endothelial cell activation by coplanar polychlorinated biphenyls. Toxicol Appl Pharmacol (2010) 1.01
Dominant negative PPARγ promotes atherosclerosis, vascular dysfunction, and hypertension through distinct effects in endothelium and vascular muscle. Am J Physiol Regul Integr Comp Physiol (2013) 1.00
Cytokines in atherosclerosis: Key players in all stages of disease and promising therapeutic targets. Cytokine Growth Factor Rev (2015) 1.00
The effects of second-hand smoke on biological processes important in atherogenesis. BMC Cardiovasc Disord (2007) 0.99
Signal transducer of inflammation gp130 modulates atherosclerosis in mice and man. J Exp Med (2007) 0.97
Single nucleotide polymorphisms in monocyte chemoattractant protein-1 and its receptor act synergistically to increase the risk of carotid atherosclerosis. Cerebrovasc Dis (2009) 0.94
Monocyte chemotactic protein-1 promotes inflammatory vascular repair of murine carotid aneurysms via a macrophage inflammatory protein-1α and macrophage inflammatory protein-2-dependent pathway. Circulation (2011) 0.93
Dominant-negative mutation of monocyte chemoattractant protein-1 prevents vulnerable plaques from rupture in rabbits independent of serum lipid levels. J Cell Mol Med (2008) 0.93
Transplanted perivascular adipose tissue accelerates injury-induced neointimal hyperplasia: role of monocyte chemoattractant protein-1. Arterioscler Thromb Vasc Biol (2014) 0.90
An oxidized lipid-peroxisome proliferator-activated receptor gamma-chemokine pathway in the regulation of macrophage-vascular smooth muscle cell adhesion. Trends Cardiovasc Med (2007) 0.89
Interleukin-27 receptor limits atherosclerosis in Ldlr-/- mice. Circ Res (2012) 0.89
Local gene silencing of monocyte chemoattractant protein-1 prevents vulnerable plaque disruption in apolipoprotein E-knockout mice. PLoS One (2012) 0.86
Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis. J Biol Chem (2010) 0.86
Recombinant human erythropoietin suppresses endothelial cell apoptosis and reduces the ratio of Bax to Bcl-2 proteins in the aortas of apolipoprotein E-deficient mice. J Cardiovasc Pharmacol (2011) 0.86
Association between circulating leukocyte subtype counts and carotid intima-media thickness in Japanese subjects with type 2 diabetes. Cardiovasc Diabetol (2013) 0.85
Therapeutic implications of chemokine-mediated pathways in atherosclerosis: realistic perspectives and utopias. Acta Pharmacol Sin (2010) 0.85
Protein kinase C-δ (PKCδ) regulates proinflammatory chemokine expression through cytosolic interaction with the NF-κB subunit p65 in vascular smooth muscle cells. J Biol Chem (2014) 0.85
Resveratrol inhibits expression and binding activity of the monocyte chemotactic protein-1 receptor, CCR2, on THP-1 monocytes. Atherosclerosis (2007) 0.85
Ethanol inhibits monocyte chemotactic protein-1 expression in interleukin-1{beta}-activated human endothelial cells. Am J Physiol Heart Circ Physiol (2005) 0.83
Interleukin-4, Oxidative Stress, Vascular Inflammation and Atherosclerosis. Biomol Ther (Seoul) (2010) 0.82
Y-box binding protein 1 and RNase UK114 mediate monocyte chemoattractant protein 1 mRNA stability in vascular smooth muscle cells. Mol Cell Biol (2012) 0.82
In vivo validation of signaling pathways regulating human monocyte chemotaxis. J Immunol Methods (2007) 0.82
Disruption of p21-activated kinase 1 gene diminishes atherosclerosis in apolipoprotein E-deficient mice. Nat Commun (2015) 0.81
Analysis of inflammation- and atherosclerosis-related gene polymorphisms in branch retinal vein occlusion. Mol Vis (2009) 0.80
Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient mice. Cardiovasc Pathol (2012) 0.80
Regulation of atherogenesis by chemokines and chemokine receptors. Arch Immunol Ther Exp (Warsz) (2012) 0.80
Homocysteine augments cytokine-induced chemokine expression in human vascular smooth muscle cells: implications for atherogenesis. Inflammation (2001) 0.78
Effects of Calcium Fructoborate on Levels of C-Reactive Protein, Total Cholesterol, Low-Density Lipoprotein, Triglycerides, IL-1β, IL-6, and MCP-1: a Double-blind, Placebo-controlled Clinical Study. Biol Trace Elem Res (2014) 0.78
3',4'-Dihydroxyflavonol down-regulates monocyte chemoattractant protein-1 in smooth muscle: role of focal adhesion kinase and PDGF receptor signalling. Br J Pharmacol (2009) 0.78
Role of NADPH oxidase in interleukin-4-induced monocyte chemoattractant protein-1 expression in vascular endothelium. Inflamm Res (2010) 0.78
CCR2 and coronary artery disease: a woscops substudy. BMC Res Notes (2010) 0.78
Hematopoietic Fas deficiency does not affect experimental atherosclerotic lesion formation despite inducing a proatherogenic state. Am J Pathol (2011) 0.78
Biological function and mechanism of MALAT-1 in renal cell carcinoma proliferation and apoptosis: role of the MALAT-1-Livin protein interaction. J Physiol Sci (2016) 0.77
Macrophages in vascular inflammation and atherosclerosis. Pflugers Arch (2017) 0.76
The effect of AVE 0991, nebivolol and doxycycline on inflammatory mediators in an apoE-knockout mouse model of atherosclerosis. Med Sci Monit (2012) 0.76
Exenatide and metformin express their anti-inflammatory effects on human monocytes/macrophages by the attenuation of MAPKs and NFκB signaling. Naunyn Schmiedebergs Arch Pharmacol (2016) 0.76
The Impact of CDH13 Polymorphism and Statin Administration on TG/HDL Ratio in Cardiovascular Patients. Yonsei Med J (2015) 0.75
Effect of PKC-β Signaling Pathway on Expression of MCP-1 and VCAM-1 in Different Cell Models in Response to Advanced Glycation End Products (AGEs). Toxins (Basel) (2015) 0.75
A Novel ASK Inhibitor AGI-1067 Inhibits TLR-4-Mediated Activation of ASK1 by Preventing Dissociation of Thioredoxin from ASK1. Cardiovasc Pharm Open Access (2015) 0.75
Therapeutic approaches in the stimulation of the coronary collateral circulation. Curr Cardiol Rev (2014) 0.75
Induced Pluripotent Stem Cell-Derived Endothelial Cells Overexpressing Interleukin-8 Receptors A/B and/or C-C Chemokine Receptors 2/5 Inhibit Vascular Injury Response. Stem Cells Transl Med (2017) 0.75
Loss of ADAMTS4 reduces high fat diet-induced atherosclerosis and enhances plaque stability in ApoE(-/-) mice. Sci Rep (2016) 0.75
Influence of fatty acids in maternal diet on atherogenesis in offspring of LDL receptor-deficient mice. Int J Clin Exp Med (2012) 0.75
Genome-wide microarray analyses identify the protein C receptor as a novel calcineurin/nuclear factor of activated T cells-dependent gene in vascular smooth muscle cell phenotypic modulation. Arterioscler Thromb Vasc Biol (2011) 0.75
The Role of CC-Chemokines in the Regulation of Angiogenesis. Int J Mol Sci (2016) 0.75
Angiopoietin-1 promotes atherosclerosis by increasing the proportion of circulating Gr1+ monocytes. Cardiovasc Res (2017) 0.75
Novel molecular targets for coronary angiogenesis and ischemic heart disease. Coron Artery Dis (2017) 0.75
Absence of monocyte chemoattractant protein-1 reduces atherosclerosis in low density lipoprotein receptor-deficient mice. Mol Cell (1998) 7.46
Abnormalities in monocyte recruitment and cytokine expression in monocyte chemoattractant protein 1-deficient mice. J Exp Med (1998) 6.52
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev (2001) 6.15
Chemokines and disease. Nat Immunol (2001) 5.62
The American College of Rheumatology 1991 revised criteria for the classification of global functional status in rheumatoid arthritis. Arthritis Rheum (1992) 4.89
Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med (2001) 3.96
Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature (2000) 3.81
Medicine. Communicating statistical information. Science (2000) 3.73
MCP-1 deficiency reduces susceptibility to atherosclerosis in mice that overexpress human apolipoprotein B. J Clin Invest (1999) 3.21
A model of dual attitudes. Psychol Rev (2000) 2.90
Wound healing in MIP-1alpha(-/-) and MCP-1(-/-) mice. Am J Pathol (2001) 2.34
Apolipoprotein A-I is required for cholesteryl ester accumulation in steroidogenic cells and for normal adrenal steroid production. J Clin Invest (1996) 2.10
Alveolar macrophage-derived cytokines induce monocyte chemoattractant protein-1 expression from human pulmonary type II-like epithelial cells. J Biol Chem (1991) 2.06
Reciprocal Rb inactivation and p16INK4 expression in primary lung cancers and cell lines. Cancer Res (1995) 1.99
Monocyte chemoattractant protein 1-dependent leukocytic infiltrates are responsible for autoimmune disease in MRL-Fas(lpr) mice. J Exp Med (1999) 1.94
Fibronectin and proteoglycans as determinants of cell-substratum adhesion. J Supramol Struct (1979) 1.93
High level monocyte chemoattractant protein-1 expression in transgenic mice increases their susceptibility to intracellular pathogens. J Immunol (1995) 1.87
Monocyte chemoattractant protein-1. Chem Immunol (1999) 1.85
The usage of a simplified self-titration dosing guideline (303 Algorithm) for insulin detemir in patients with type 2 diabetes--results of the randomized, controlled PREDICTIVE 303 study. Diabetes Obes Metab (2007) 1.81
Two hot spot mutant p53 mouse models display differential gain of function in tumorigenesis. Cell Death Differ (2013) 1.77
A novel p16INK4A transcript. Cancer Res (1995) 1.74
Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest (2001) 1.72
A dominant negative inhibitor indicates that monocyte chemoattractant protein 1 functions as a dimer. Mol Cell Biol (1995) 1.68
Biochemical and biologic characterization of murine monocyte chemoattractant protein-1. Identification of two functional domains. J Immunol (1994) 1.67
Structure/activity analysis of human monocyte chemoattractant protein-1 (MCP-1) by mutagenesis. Identification of a mutated protein that inhibits MCP-1-mediated monocyte chemotaxis. J Biol Chem (1994) 1.62
Monocyte chemoattractant protein-1 promotes macrophage-mediated tubular injury, but not glomerular injury, in nephrotoxic serum nephritis. J Clin Invest (1999) 1.62
Transgenic monocyte chemoattractant protein-1 (MCP-1) in pancreatic islets produces monocyte-rich insulitis without diabetes: abrogation by a second transgene expressing systemic MCP-1. J Immunol (1997) 1.57
MCP-1 expression by rat type II alveolar epithelial cells in primary culture. J Immunol (1993) 1.49
p16INK4A participates in a G1 arrest checkpoint in response to DNA damage. Mol Cell Biol (1998) 1.46
Circadian regulation of bioluminescence in Gonyaulax involves translational control. Proc Natl Acad Sci U S A (1989) 1.46
Glycosaminoglycans in the substrate adhesion sites of normal and virus-transformed murine cells. Biochemistry (1979) 1.44
Two functionally distinct pools of glycosaminoglycan in the substrate adhesion site of murine cells. J Cell Biol (1978) 1.43
Monocyte chemoattractant protein-1-induced tissue inflammation is critical for the development of renal injury but not type 2 diabetes in obese db/db mice. Diabetologia (2006) 1.42
Expression of the focal adhesion protein paxillin in lung cancer and its relation to cell motility. Oncogene (1999) 1.39
Monocyte chemotactic protein gene expression by cytokine-treated human retinal pigment epithelial cells. Lab Invest (1991) 1.39
An association study of 43 SNPs in 16 candidate genes with atorvastatin response. Pharmacogenomics J (2005) 1.39
A phase II trial of the cyclin-dependent kinase inhibitor flavopiridol in patients with previously untreated stage IV non-small cell lung cancer. Clin Cancer Res (2001) 1.37
Electron tomography of large, multicomponent biological structures. J Struct Biol (1997) 1.36
Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A (1996) 1.35
RNA blots: staining procedures and optimization of conditions. Nucleic Acids Res (1991) 1.30
Tissue factor is induced by monocyte chemoattractant protein-1 in human aortic smooth muscle and THP-1 cells. J Biol Chem (1997) 1.29
Critical role of MCP-1 in the pathogenesis of experimental colitis in the context of immune and enterochromaffin cells. Am J Physiol Gastrointest Liver Physiol (2006) 1.20
Ccr2 regulates the level of MCP-1/CCL2 in vitro and at inflammatory sites and controls T cell activation in response to alloantigen. Cytokine (2002) 1.18
TCF is the nuclear effector of the beta-catenin signal that patterns the sea urchin animal-vegetal axis. Dev Biol (2000) 1.17
Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Cancer Res (1995) 1.17
Monocyte chemoattractant protein-1 gene is expressed in activated neutrophils and retinoic acid-induced human myeloid cell lines. Blood (1994) 1.17
Apolipoprotein C-III(Lys58----Glu). Identification of an apolipoprotein C-III variant in a family with hyperalphalipoproteinemia. J Clin Invest (1991) 1.15
Expression of cytokine-like genes JE and KC is increased during renal ischemia. Am J Physiol (1991) 1.15
Glutamine 161 of Glut1 glucose transporter is critical for transport activity and exofacial ligand binding. J Biol Chem (1994) 1.13
Preliminary characterization of the proteoglycans in the substrate adhesion sites of normal and virus-transformed murine cells. Biochemistry (1979) 1.10
A functional IFN-gamma-inducible protein-10/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan. J Immunol (2001) 1.06
JE mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Circ Res (1992) 1.06
The murine P84 neural adhesion molecule is SHPS-1, a member of the phosphatase-binding protein family. J Neurosci (1997) 1.01
Comparison of fibroblast and T-cell activation genes. Cell Immunol (1988) 1.00
The physiology of p16(INK4A)-mediated G1 proliferative arrest. Cell Biochem Biophys (2000) 1.00
Renal expression of monocyte chemoattractant protein-1 in lupus autoimmune mice. J Am Soc Nephrol (1997) 0.99
High variation in multiple paternity of domestic cats (Felis catus L.) in relation to environmental conditions. Proc Biol Sci (1999) 0.98
Retinal pigment epithelium possesses both LDL and scavenger receptor activity. Invest Ophthalmol Vis Sci (1989) 0.95
Truncation of human squalene synthase yields active, crystallizable protein. Arch Biochem Biophys (1998) 0.93
Flavopiridol induces cell cycle arrest and p53-independent apoptosis in non-small cell lung cancer cell lines. Clin Cancer Res (1999) 0.93
Overexpression of metallothionein decreases sensitivity of pulmonary endothelial cells to oxidant injury. Am J Physiol (1997) 0.92
MCP-1-mediated chemotaxis requires activation of non-overlapping signal transduction pathways. J Leukoc Biol (1997) 0.91
The hostel outreach program: assertive case management for homeless mentally ill persons. Hosp Community Psychiatry (1993) 0.91
Monocyte adherence to endothelial cells in vitro is increased by beta-VLDL. Am J Pathol (1987) 0.91
Human fibroblasts express functional IL-2 receptors formed by the IL-2R alpha- and beta-chain subunits: association of IL-2 binding with secretion of the monocyte chemoattractant protein-1. J Immunol (1996) 0.90
The effect of low flow oxygen on sleep-disordered breathing and oxygen desaturation. A study of patients with chronic obstructive lung disease. Chest (1980) 0.90
LDL enhances monocyte adhesion to endothelial cells in vitro. Am J Pathol (1986) 0.89
p16INK4A as a human tumor suppressor. Biochim Biophys Acta (1996) 0.88
Adrenocortical response to adrenocorticotropin in heterozygous familial hypercholesterolemia. J Clin Endocrinol Metab (1984) 0.87
Hepatic veno-occlusive disease. Am J Med (1986) 0.87
Cholesteryl ester transfer protein promoter single-nucleotide polymorphisms in Sp1-binding sites affect transcription and are associated with high-density lipoprotein cholesterol. Clin Genet (2004) 0.87
Evidence for a novel signal transduction pathway activated by platelet-derived growth factor and by double-stranded RNA. Mol Cell Biol (1989) 0.87
In vivo and in vitro inhibition of JE gene expression by glucocorticoids. J Biol Chem (1991) 0.87
Stimulation of T lymphocyte proliferation by monoclonal antibodies against GD3 ganglioside. J Immunol (1987) 0.87
Will dietary omega-3 fatty acids change the composition of human milk? Am J Clin Nutr (1984) 0.87
Influence of oestrus synchronization on male reproductive success in the domestic cat (Felis catus L.). Proc Biol Sci (2001) 0.86
HMG-CoA reductase regulation: use of structurally diverse first half-reaction squalene synthetase inhibitors to characterize the site of mevalonate-derived nonsterol regulator production in cultured IM-9 cells. J Lipid Res (1999) 0.86
Taurine enhances low density lipoprotein binding. Internalization and degradation by cultured Hep G2 cells. J Biol Chem (1987) 0.86
Human keratinocyte growth-promoting activity on the surface of fibroblasts. J Cell Physiol (1991) 0.86
Lactose protects against estrogen-induced pigment gallstones in hamsters fed nutritionally adequate purified diets. J Nutr (1989) 0.85
Serotonin increases DNA synthesis in rat proximal and distal pulmonary vascular smooth muscle cells in culture. Am J Physiol (1994) 0.85
Menopause, medroxyprogesterone and breathing during sleep. Am J Med (1981) 0.85
Severe type III hyperlipoproteinemia associated with unusual apolipoprotein E1 phenotype and epsilon 1/'null' genotype. Eur J Clin Invest (1992) 0.84
Characterization of five new mutants in the carboxyl-terminal domain of human apolipoprotein E: no cosegregation with severe hyperlipidemia. Am J Hum Genet (1993) 0.84
CP-225,917 and CP-263,114, novel Ras farnesylation inhibitors from an unidentified fungus. I. Taxonomy, fermentation, isolation, and biochemical properties. J Antibiot (Tokyo) (1997) 0.83
CYP2D6 genotyping as an alternative to phenotyping for determination of metabolic status in a clinical trial setting. AAPS PharmSci (2000) 0.82
Similarities and differences in the ultrastructure of two hormone-dependent and one independent human breast carcinoma grown in athymic nude mice: comparison with the rat DMBA-induced tumor and normal secretory mammocytes. J Submicrosc Cytol (1984) 0.81
3-(4-chlorophenyl)-2-(4-diethylaminoethoxyphenyl)-A-pentenonitrile monohydrogen citrate and related analogs. Reversible, competitive, first half-reaction squalene synthetase inhibitors. Biochem Pharmacol (1997) 0.80
Cloning, expression and pharmacological characterization of rabbit adenosine A1 and A3 receptors. J Pharmacol Exp Ther (1997) 0.80
The social function of tail up in the domestic cat (Felis silvestris catus). Behav Processes (2008) 0.80
Chromosomal mapping of the human M6 genes. Genomics (1996) 0.79
Platelet-derived growth factor generates at least two distinct intracellular signals that modulate gene expression. Cold Spring Harb Symp Quant Biol (1988) 0.79
Screening for naturally occurring apolipoprotein A-I variants: apo A-I(delta K107) is associated with low HDL-cholesterol levels in men but not in women. Hum Genet (1995) 0.78
Selection of a Brucella vaccine strain of low residual virulence by chemical mutagenesis. J Med Microbiol (1989) 0.78
Comparison of the expression of two immediate early gene proteins, FosB and Fos in the rat preoptic area, hypothalamus and brainstem during pregnancy, parturition and lactation. Neurosci Res (1998) 0.78
An Adaptive Structure Neural Networks with Application to EEG Automatic Seizure Detection. Neural Netw (1996) 0.78
Organotypic culture of fetal rat lung: evaluation and comparison with organ culture. Am Rev Respir Dis (1981) 0.77